Sign In
Buy SMTI
$33.86
-0.200 (-0.587%)
At Close: Jul 31, 2026
Sanara MedTech Inc. (SMTI) Q3 2023 Earnings Call Transcript
01:27pm, Tuesday, 14'th Nov 2023
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2023 Results Conference Call November 14, 2023 9:00 AM ET Company Participants Callon Nichols - Vice President of Corporate Operations Ron Nixon - Executive Chair
Sanara MedTech Inc. Announces Third Quarter 2023 Results
04:05pm, Monday, 13'th Nov 2023
FORT WORTH, TX, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI),
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
09:15am, Monday, 30'th Oct 2023
FORT WORTH, TX, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI),
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates
09:15am, Tuesday, 10'th Oct 2023
FORT WORTH, TX, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on develop
Sanara MedTech: Surgical Sales Set To Accelerate While Post Acute Care Platform Develops
07:18am, Wednesday, 13'th Sep 2023
CellerateRX was approved to be sold in over 1200 new locations. BIASURGE was approved by the FDA and is set to launch commercially in Q4. TEXAGEN sales growing extremely fast (86% QoQ).
Sanara MedTech to Participate in Two Upcoming Conferences
09:15am, Tuesday, 12'th Sep 2023
FORT WORTH, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on develo
Sanara Medtech, Inc. (SMTI) Q2 2023 Earnings Call Transcript
01:51pm, Tuesday, 15'th Aug 2023
Sanara Medtech, Inc. (NASDAQ:SMTI ) Q2 2023 Earnings Conference Call August 15, 2023 9:00 AM ET Company Participants Callon Nichols - VP, Corporate Operations Ron Nixon - Executive Chairman Zach Flemi
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
09:15am, Wednesday, 02'nd Aug 2023
FORT WORTH, TX, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI),
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
04:05pm, Tuesday, 01'st Aug 2023
FORT WORTH, TX, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI),
Down -14.23% in 4 Weeks, Here's Why Sanara MedTech Inc. (SMTI) Looks Ripe for a Turnaround
10:42am, Wednesday, 24'th May 2023
The heavy selling pressure might have exhausted for Sanara MedTech Inc. (SMTI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
09:15am, Wednesday, 03'rd May 2023
FORT WORTH, TX, May 03, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developi
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call Dates
09:15am, Monday, 06'th Mar 2023
FORT WORTH, TX, March 06, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI)
What Makes Sanara MedTech Inc. (SMTI) a Good Fit for 'Trend Investing'
10:32am, Friday, 03'rd Feb 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sanara MedTech Inc. (SMTI) could be a great choice. It is one of the several stocks that passed through our "Re
Sanara MedTech: A High Growth Micro Cap Disrupting The Wound And Skin Care Space
12:22pm, Friday, 09'th Dec 2022
A micro cap health tech company following a path to large cap potential. A management team with vision, ownership, operational expertise, domain knowledge and that trust each other.
Sanara MedTech: Triple-Digit Revenue Upside In Q3, Expanding Footprint, Reaffirm Buy
04:24am, Thursday, 08'th Dec 2022
Tremendous growth during the quarter with 124% revenue upside from this time last year. Continues to expand its footprint and sales channels, pushing towards its market goals.
